We are monitoring the impact of COVID-19 on Vaccine Contract Manufacturing Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 7574
Share on
Share on

Global Vaccine Contract Manufacturing Market Size, Share, Trends and Growth Analysis Report – Segmented By Service Type, Product Type, Vaccine Type and Region - Industry Forecast (2021 to 2026)

Pulished: April, 2021
ID: 7574
Pages: 175

Global Vaccine Contract Manufacturing Market Size (2021 to 2026)

The Global Vaccine Contract Manufacturing Market size is estimated to be worth USD 1476.3 million by 2026 from USD 990.9 million in 2021. It is expected to rise at a CAGR of 8.3% during the forecast period.

A vaccine is a biological element prepared to assist the immunity of a person against one or several diseases. Contracted Vaccine manufacturing establishment has higher qualitative and quantitative controlling standards with a significant margin of fixed costs, and production & development linked difficulties, have limited competition between vaccine manufacturers.

MARKET DRIVERS:

Y-o-Y growth in the number of R&D activities for novel vaccines, rising biotechnology advancements, and the latest technological developments are majorly escalating the global vaccine contract manufacturing market.

According to the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), in 2020, research-based pharmaceutical industries have been engaged 2 million and above for research and development and offer medicines that advance their lives globally. The demand for contract manufacturing is increasing significantly, which in turn drives market growth globally. Factors such as growing demand for vaccines worldwide and Y-O-Y growth in chronic disease incidence are further propelling the global vaccine contract manufacturing market.

The growing number of infectious diseases such as COVID19 and hepatitis-B is accelerating the global vaccine contract manufacturing market growth rate. Rising awareness levels regarding the vaccines' advantages among developed countries is expected to impact the vaccine contract manufacturing market growth positively.

MARKET RESTRAINTS:

However, issues associated with the manufacturing setups and vaccine production hinder the vaccine contract manufacturing market growth. The costs associated with the vaccination and patent expiration may negatively impact the market growth during the forecast period. Strict regulatory guidelines united with prominent rigid cost, production, and advancements-related hurdles have an incomplete contest between vaccine manufacturers. 

Impact of COVID-19 on the global vaccine contract manufacturing market:

The novel coronavirus (COVID19) has created a positive impact on the vaccine contract manufacturing market. As the GlobalData Pharma Intelligence Centre, the pharmaceutical companies have recognized 42 contract manufacturing service terms and conditions for 26 sequence COVID-19 vaccines. In March 2020, LabCorp introduced the NAA test to identify coronavirus in the United States. The NAA test is coupled in patient care, and the virus is to spread continuously. The industry is concentrating on novel drug discovery, test kits, and assisting the advancements of vaccines and treatments for COVID 19 across the Covance Drug Development business to develop patients' health and lives. 

REPORT COVERAGE:

REPORT METRIC

DETAILS

Market Size Available

2020 to 2026

Base Year

2020

Forecast Period

2021 to 2026

Segments Covered

By Service Type, Product Type, Vaccine Type, and Region

Various Analyses Covered

Global, Regional & Country Level Analysis, Segment-Level Analysis, Drivers, Restraints, Opportunities, Challenges, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities

Regions Covered

North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

 

This research report on the global vaccine contract manufacturing market has been segmented and sub-segmented based on the service type, product type, vaccine type, and region.

Vaccine Contract Manufacturing Market - By Service Type:

  • Bulk Product
  • Fill Finish

The full Finish service type segment is expected to account for the largest share in the global vaccine contract manufacturing market during the forecast period based on the service type.

Vaccine Contract Manufacturing Market - By Product Type:

  • Single Vaccine
    • Influenza Virus
    • Ebola Virus
    • Chickenpox
    • Tetanus
    • Tuberculosis
    • Polio
    • Smallpox
    • Others
  • Combination Type

The single vaccine product type is more familiar amid the vaccine contract manufacturing market.

Global Vaccine Contract Manufacturing Market – By Vaccine Type:

  • Inactivated Vaccines
  • Conjugate Vaccines
  • Live Attenuated Vaccines
  • Toxoid Vaccines
  • Recombinant Vector Vaccines
  • Subunit Vaccines
  • Synthetic Vaccines

Based on the vaccine type, the live attenuated vaccines segment is estimated to grow at a substantial CAGR during the assessment period. Due to many licensed oral or intranasal administration products, the segment's growth is the potentiality to induce appropriate handling circumstances about preservation.

The inactivated vaccines segment was the market leader in 2019. These vaccines are protective and relatively more stable than other types.

The subunit vaccines segment to register a stable growth rate during the forecast period due to continuous research to develop re-combination subunit vaccines opposing the Hepatitis C virus.

Global Vaccine Contract Manufacturing Market – By Region:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • The Middle East and Africa

Regionally, North America takeovers the global market, having the existence of a large number of contract manufacturing organizations (CMOS). About 40 CMOs are present in diverse locations in the U.S. Europe is the next major market for vaccine contract manufacturing, with about 20 CMOs located in Germany, U.K, and France. The Asia Pacific market is about to expand at a high growth rate throughout the forecast period due to the rapidly growing economies of India and China.

KEY MARKET PARTICIPANTS:

Some of the key competitors operating in the global vaccine contract manufacturing market profiled in this report are Thomas Jefferson University, Goodwin Biotechnology Inc., BioMARK, Emergent BioSolutions, Soligenix Inc., Catalent Biologics, Minneapolis Medical Research Foundation (MMRF), Bavarian Nordic A/S, and FUJIFILM Diosynth Biotechnologies.

RECENT MARKET HAPPENINGS :

  • In September 2017, the acquisition of freeze-dried IMVAMUNE smallpox vaccine had won a source contract from the Biomedical Advanced Research and Development Authority (BARDA) for Bavarian Nordic A/S. The market player supports facilities for clinical development and validation for product manufacturing. 
  • In December 2020, Soligenix, Inc., a biopharmaceutical company, focuses on advancing and commercializing products in treating rare diseases and vaccine RiVax.
  • In August 2020, Catalent Inc. provided drug substance production to AstraZeneca for adenovirus vector-based COVID 19 vaccine. 

1. Introduction                                 

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Service Type                              

                                5.1.1 Introduction           

                                5.1.2 Bulk Product           

                                5.1.3 Fill Finish  

                                5.1.4  Y-o-Y Growth Analysis, By Service Type     

                                5.1.5  Market Attractiveness Analysis, By Service Type   

                                5.1.6  Market Share Analysis, By Service Type    

                5.2 Product Type                             

                                5.2.1 Introduction           

                                5.2.2 Single Vaccine        

                                                5.2.2.1 Influenza Virus

                                                5.2.2.2 Chicken Pox

                                                5.2.2.3 Ebola Virus

                                                5.2.2.4 Tetanus

                                                5.2.2.5 Tuberculosis

                                                5.2.2.6 Polio

                                                5.2.2.7 Small Pox

                                5.2.3 Combination Vaccine          

                                5.2.4 Y-o-Y Growth Analysis, By Product Type    

                                5.2.5 Market Attractiveness Analysis, By Product Type  

                                5.2.6 Market Share Analysis, By Product Type    

                5.3 Vaccine Type                             

                                5.3.1 Introduction           

                                5.3.2 Inactivated Vaccines           

                                5.3.3 Conjugate Vaccines             

                                5.3.4 Live Attenuated    

                                5.3.5 Toxoid Vaccines    

                                5.3.6 Recombinant Vector Vaccines        

                                5.3.7 Subunit Vaccines  

                                5.3.8 Synthetic Vaccines               

                                5.3.9 Y-o-Y Growth Analysis, By Vaccine Type     

                                5.3.10  Market Attractiveness Analysis, By Vaccine Type               

                                5.3.11  Market Share Analysis, By Vaccine Type

6. Geographical Analysis                                              

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Service Type

                                                6.1.3.3 By Product Type

                                                6.1.3.4 By Vaccine Type

                                6.1.4  Market Attractiveness Analysis     

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Service Type

                                                6.1.4.3 By Product Type

                                                6.1.4.4 By Vaccine Type

                                6.1.5  Market Share Analysis      

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Service Type

                                                6.1.5.3 By Product Type

                                                6.1.5.4 By Vaccine Type

                6.2 North America                          

                                6.1.1 Introduction           

                                6.1.2 United States         

                                6.1.3 Canada     

                6.3 Europe                         

                                6.2.1 Introduction           

                                6.2.2 U.K             

                                6.2.3 Spain         

                                6.2.4 Germany 

                                6.2.5 Italy            

                                6.2.6 France       

                6.4 Asia-Pacific                 

                                6.3.1 Introduction           

                                6.3.2 China         

                                6.3.3 India          

                                6.3.4 Japan         

                                6.3.5 Australia   

                                6.3.6 South Korea           

                6.5 Latin America                             

                                6.4.1 Introduction           

                                6.4.2 Brazil          

                                6.4.3 Argentina

                                6.4.4 Mexico     

                                6.4.5 Rest of Latin America          

                6.6 Middle East & Africa                               

                                6.5.1 Introduction           

                                6.5.2 Middle-East            

                                6.5.3 Africa         

7. Strategic Analysis                                       

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8. Market Leaders' Analysis                                        

                8.1 Bavarian Nordic A/S                

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Thomas Jefferson University                              

                8.3 Goodwin Biotechnology Inc.                               

                8.4 BioMARK                     

                8.5 Emergent BioSolutions                          

                8.6 Soligenix Inc.                              

                8.7 Catalent Biologics                     

                8.8 Minneapolis Medical Research Foundation                  

                8.9 FUJIFILM Diosynth Biotechnologies                 

9. Competitive Landscape                                           

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10. Market Outlook and Investment Opportunities                                         

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Global and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • The segment-level analysis in terms of the service center, by Product type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographics, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the microenvironment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development
  • A comprehensive list of key market players along with with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis, and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market

                                                                                                                          

  1. Global Vaccine Contract Manufacturing Market, By Region, From 2021 to 2026 (USD Million)
  2. Global Vaccine Contract Manufacturing Market, By Service Type, From 2021 to 2026 (USD Million)
  3. Global Bulk Type Market, By Region, From 2021 to 2026 (USD Million)
  4. Global Fill Finish Market, By Region, From 2021 to 2026 (USD Million)
  5. Global Vaccine Contract Manufacturing Market, By Product Type, From 2021 to 2026 (USD Million)
  6. Global Single Vaccine Market, By Region, From 2021 to 2026 (USD Million)
  7. Global Combination Vaccine Market, By Region, From 2021 to 2026 (USD Million)
  8. Global Vaccine Contract Manufacturing Market, By Vaccine Type, From 2021 to 2026 (USD Million)
  9. Global Inactivated Vaccine Market, By Region, From 2021 to 2026 (USD Million)
  10. Global Conjugated Vaccine Market, By Region, From 2021 to 2026 (USD Million)
  11. Global Recombinant Vector Vaccine Market, By Region, From 2021 to 2026 (USD Million)
  12. Global Live Attenuated Vaccine Market, By Region, From 2021 to 2026 (USD Million)
  13. Global Toxoid Vaccine Market, By Region, From 2021 to 2026 (USD Million)
  14. Global Sub Unite Vaccine Market, By Region, From 2021 to 2026 (USD Million)
  15. Global Synthetic Vaccine Market, By Region, From 2021 to 2026 (USD Million)
  16. Global Vaccine Contract Manufacturing Market, By Single Vaccine, From 2021 to 2026 (USD Million)
  17. Global Influenza Virus Market, By Region, From 2021 to 2026 (USD Million)
  18. Global Chicken Pox Market, By Region, From 2021 to 2026 (USD Million)
  19. Global Ebola Virus Market, By Region, From 2021 to 2026 (USD Million)
  20. Global Tetanus Market, By Region, From 2021 to 2026 (USD Million)
  21. Global Tubercolosis Market, By Region, From 2021 to 2026 (USD Million)
  22. Global Polio Market, By Region, From 2021 to 2026 (USD Million)
  23. Global Small Pox Market, By Region, From 2021 to 2026 (USD Million)
  24. North America Vaccine Contract Manufacturing Market, By Service Type, From 2021 to 2026 (USD Million)
  25. North America Bulk Type Market, By Region, From 2021 to 2026 (USD Million)
  26. North America Fill Finish Market, By Region, From 2021 to 2026 (USD Million)
  27. North America Vaccine Contract Manufacturing Market, By Product Type, From 2021 to 2026 (USD Million)
  28. North America Single Vaccine Market, By Region, From 2021 to 2026 (USD Million)
  29. North America Combination Vaccine Market, By Region, From 2021 to 2026 (USD Million)
  30. North America Vaccine Contract Manufacturing Market, By Vaccine Type, From 2021 to 2026 (USD Million)
  31. North America Inactivated Vaccine Market, By Region, From 2021 to 2026 (USD Million)
  32. North America Conjugated Vaccine Market, By Region, From 2021 to 2026 (USD Million)
  33. North America Recombinant Vector Vaccine Market, By Region, From 2021 to 2026 (USD Million)
  34. North America Live Attenuated Vaccine Market, By Region, From 2021 to 2026 (USD Million)
  35. North America Toxoid Vaccine Market, By Region, From 2021 to 2026 (USD Million)
  36. North America Sub Unite Vaccine Market, By Region, From 2021 to 2026 (USD Million)
  37. North America Synthetic Vaccine Market, By Region, From 2021 to 2026 (USD Million)
  38. United States Vaccine Contract Manufacturing Market, By Service Type, From 2021 to 2026 (USD Million)
  39. United States Vaccine Contract Manufacturing Market, By Product Type, From 2021 to 2026 (USD Million)
  40. United States Vaccine Contract Manufacturing Market, By Vaccine Type, From 2021 to 2026 (USD Million)
  41. Canada Vaccine Contract Manufacturing Market, By Service Type, From 2021 to 2026 (USD Million)
  42. Canada Vaccine Contract Manufacturing Market, By Product Type, From 2021 to 2026 (USD Million)
  43. Canada Vaccine Contract Manufacturing Market, By Vaccine Type, From 2021 to 2026 (USD Million)
  44. North America Vaccine Contract Manufacturing Market, By Single Vaccine, From 2021 to 2026 (USD Million)
  45. North America Influenza Virus Market, By Region, From 2021 to 2026 (USD Million)
  46. North America Chicken Pox Market, By Region, From 2021 to 2026 (USD Million)
  47. North America Ebola Virus Market, By Region, From 2021 to 2026 (USD Million)
  48. North America Tetanus Market, By Region, From 2021 to 2026 (USD Million)
  49. North America Tubercolosis Market, By Region, From 2021 to 2026 (USD Million)
  50. North America Polio Market, By Region, From 2021 to 2026 (USD Million)
  51. North America Small Pox Market, By Region, From 2021 to 2026 (USD Million)
  52. United States Vaccine Contract Manufacturing Market, By Single Vaccine, From 2021 to 2026 (USD Million)
  53. Canada Vaccine Contract Manufacturing Market, By Single Vaccine, From 2021 to 2026 (USD Million)
  54. Europe Vaccine Contract Manufacturing Market, By Service Type, From 2021 to 2026 (USD Million)
  55. Europe Bulk Type Market, By Region, From 2021 to 2026 (USD Million)
  56. Europe Fill Finish Market, By Region, From 2021 to 2026 (USD Million)
  57. Europe Vaccine Contract Manufacturing Market, By Product Type, From 2021 to 2026 (USD Million)
  58. Europe Single Vaccine Market, By Region, From 2021 to 2026 (USD Million)
  59. Europe Combination Vaccine Market, By Region, From 2021 to 2026 (USD Million)
  60. Europe Vaccine Contract Manufacturing Market, By Vaccine Type, From 2021 to 2026 (USD Million)
  61. Europe Inactivated Vaccine Market, By Region, From 2021 to 2026 (USD Million)
  62. Europe Conjugated Vaccine Market, By Region, From 2021 to 2026 (USD Million)
  63. Europe Recombinant Vector Vaccine Market, By Region, From 2021 to 2026 (USD Million)
  64. Europe Live Attenuated Vaccine Market, By Region, From 2021 to 2026 (USD Million)
  65. Europe Toxoid Vaccine Market, By Region, From 2021 to 2026 (USD Million)
  66. Europe Sub Unite Vaccine Market, By Region, From 2021 to 2026 (USD Million)
  67. Europe Synthetic Vaccine Market, By Region, From 2021 to 2026 (USD Million)
  68. U.K. Vaccine Contract Manufacturing Market, By Service Type, From 2021 to 2026 (USD Million)
  69. U.K. Vaccine Contract Manufacturing Market, By Product Type, From 2021 to 2026 (USD Million)
  70. U.K. Vaccine Contract Manufacturing Market, By Vaccine Type, From 2021 to 2026 (USD Million)
  71. Germany Vaccine Contract Manufacturing Market, By Service Type, From 2021 to 2026 (USD Million)
  72. Germany Vaccine Contract Manufacturing Market, By Product Type, From 2021 to 2026 (USD Million)
  73. Germany Vaccine Contract Manufacturing Market, By Vaccine Type, From 2021 to 2026 (USD Million)
  74. France Vaccine Contract Manufacturing Market, By Service Type, From 2021 to 2026 (USD Million)
  75. France Vaccine Contract Manufacturing Market, By Product Type, From 2021 to 2026 (USD Million)
  76. France Vaccine Contract Manufacturing Market, By Vaccine Type, From 2021 to 2026 (USD Million)
  77. Italy Vaccine Contract Manufacturing Market, By Service Type, From 2021 to 2026 (USD Million)
  78. Italy Vaccine Contract Manufacturing Market, By Product Type, From 2021 to 2026 (USD Million)
  79. Italy Vaccine Contract Manufacturing Market, By Vaccine Type, From 2021 to 2026 (USD Million)
  80. Spain Vaccine Contract Manufacturing Market, By Service Type, From 2021 to 2026 (USD Million)
  81. Spain Vaccine Contract Manufacturing Market, By Product Type, From 2021 to 2026 (USD Million)
  82. Spain Vaccine Contract Manufacturing Market, By Vaccine Type, From 2021 to 2026 (USD Million)
  83. Europe Vaccine Contract Manufacturing Market, By Single Vaccine, From 2021 to 2026 (USD Million)
  84. Europe Influenza Virus Market, By Region, From 2021 to 2026 (USD Million)
  85. Europe Chicken Pox Market, By Region, From 2021 to 2026 (USD Million)
  86. Europe Ebola Virus Market, By Region, From 2021 to 2026 (USD Million)
  87. Europe Tetanus Market, By Region, From 2021 to 2026 (USD Million)
  88. Europe Tubercolosis Market, By Region, From 2021 to 2026 (USD Million)
  89. Europe Polio Market, By Region, From 2021 to 2026 (USD Million)
  90. Europe Small Pox Market, By Region, From 2021 to 2026 (USD Million)
  91. U.K. Vaccine Contract Manufacturing Market, By Single Vaccine, From 2021 to 2026 (USD Million)
  92. Germany Vaccine Contract Manufacturing Market, By Single Vaccine, From 2021 to 2026 (USD Million)
  93. France Vaccine Contract Manufacturing Market, By Single Vaccine, From 2021 to 2026 (USD Million)
  94. Italy Vaccine Contract Manufacturing Market, By Single Vaccine, From 2021 to 2026 (USD Million)
  95. Spain Vaccine Contract Manufacturing Market, By Single Vaccine, From 2021 to 2026 (USD Million)
  96. Asia Pacific Vaccine Contract Manufacturing Market, By Service Type, From 2021 to 2026 (USD Million)
  97. Asia Pacific Bulk Type Market, By Region, From 2021 to 2026 (USD Million)
  98. Asia Pacific Fill Finish Market, By Region, From 2021 to 2026 (USD Million)
  99. Asia Pacific Vaccine Contract Manufacturing Market, By Product Type, From 2021 to 2026 (USD Million)
  100. Asia Pacific Single Vaccine Market, By Region, From 2021 to 2026 (USD Million)
  101. Asia Pacific Combination Vaccine Market, By Region, From 2021 to 2026 (USD Million)
  102. Asia Pacific Vaccine Contract Manufacturing Market, By Vaccine Type, From 2021 to 2026 (USD Million)
  103. Asia Pacific Inactivated Vaccine Market, By Region, From 2021 to 2026 (USD Million)
  104. Asia Pacific Conjugated Vaccine Market, By Region, From 2021 to 2026 (USD Million)
  105. Asia Pacific Recombinant Vector Vaccine Market, By Region, From 2021 to 2026 (USD Million)
  106. Asia Pacific Live Attenuated Vaccine Market, By Region, From 2021 to 2026 (USD Million)
  107. Asia Pacific Toxoid Vaccine Market, By Region, From 2021 to 2026 (USD Million)
  108. Asia Pacific Sub Unite Vaccine Market, By Region, From 2021 to 2026 (USD Million)
  109. Asia Pacific Synthetic Vaccine Market, By Region, From 2021 to 2026 (USD Million)
  110. Japan Vaccine Contract Manufacturing Market, By Service Type, From 2021 to 2026 (USD Million)
  111. Japan Vaccine Contract Manufacturing Market, By Product Type, From 2021 to 2026 (USD Million)
  112. Japan Vaccine Contract Manufacturing Market, By Vaccine Type, From 2021 to 2026 (USD Million)
  113. China Vaccine Contract Manufacturing Market, By Service Type, From 2021 to 2026 (USD Million)
  114. China Vaccine Contract Manufacturing Market, By Product Type, From 2021 to 2026 (USD Million)
  115. China Vaccine Contract Manufacturing Market, By Vaccine Type, From 2021 to 2026 (USD Million)
  116. India Vaccine Contract Manufacturing Market, By Service Type, From 2021 to 2026 (USD Million)
  117. India Vaccine Contract Manufacturing Market, By Product Type, From 2021 to 2026 (USD Million)
  118. India Vaccine Contract Manufacturing Market, By Vaccine Type, From 2021 to 2026 (USD Million)
  119. Australia Vaccine Contract Manufacturing Market, By Service Type, From 2021 to 2026 (USD Million)
  120. Australia Vaccine Contract Manufacturing Market, By Product Type, From 2021 to 2026 (USD Million)
  121. Australia Vaccine Contract Manufacturing Market, By Vaccine Type, From 2021 to 2026 (USD Million)
  122. South Korea Vaccine Contract Manufacturing Market, By Service Type, From 2021 to 2026 (USD Million)
  123. South Korea Vaccine Contract Manufacturing Market, By Product Type, From 2021 to 2026 (USD Million)
  124. South Korea Vaccine Contract Manufacturing Market, By Vaccine Type, From 2021 to 2026 (USD Million)
  125. Asia Pacific Vaccine Contract Manufacturing Market, By Single Vaccine, From 2021 to 2026 (USD Million)
  126. Asia Pacific Influenza Virus Market, By Region, From 2021 to 2026 (USD Million)
  127. Asia Pacific Chicken Pox Market, By Region, From 2021 to 2026 (USD Million)
  128. Asia Pacific Ebola Virus Market, By Region, From 2021 to 2026 (USD Million)
  129. Asia Pacific Tetanus Market, By Region, From 2021 to 2026 (USD Million)
  130. Asia Pacific Tubercolosis Market, By Region, From 2021 to 2026 (USD Million)
  131. Asia Pacific Polio Market, By Region, From 2021 to 2026 (USD Million)
  132. Asia Pacific Small Pox Market, By Region, From 2021 to 2026 (USD Million)
  133. Japan Vaccine Contract Manufacturing Market, By Single Vaccine, From 2021 to 2026 (USD Million)
  134. China Vaccine Contract Manufacturing Market, By Single Vaccine, From 2021 to 2026 (USD Million)
  135. India Vaccine Contract Manufacturing Market, By Single Vaccine, From 2021 to 2026 (USD Million)
  136. Australia Vaccine Contract Manufacturing Market, By Single Vaccine, From 2021 to 2026 (USD Million)
  137. Latin America Vaccine Contract Manufacturing Market, By Service Type, From 2021 to 2026 (USD Million)
  138. Latin America Bulk Type Market, By Region, From 2021 to 2026 (USD Million)
  139. Latin America Fill Finish Market, By Region, From 2021 to 2026 (USD Million)
  140. Latin America Vaccine Contract Manufacturing Market, By Product Type, From 2021 to 2026 (USD Million)
  141. Latin America Single Vaccine Market, By Region, From 2021 to 2026 (USD Million)
  142. Latin America Combination Vaccine Market, By Region, From 2021 to 2026 (USD Million)
  143. Latin America Vaccine Contract Manufacturing Market, By Vaccine Type, From 2021 to 2026 (USD Million)
  144. Latin America Inactivated Vaccine Market, By Region, From 2021 to 2026 (USD Million)
  145. Latin America Conjugated Vaccine Market, By Region, From 2021 to 2026 (USD Million)
  146. Latin America Recombinant Vector Vaccine Market, By Region, From 2021 to 2026 (USD Million)
  147. Latin America Live Attenuated Vaccine Market, By Region, From 2021 to 2026 (USD Million)
  148. Latin America Toxoid Vaccine Market, By Region, From 2021 to 2026 (USD Million)
  149. Latin America Sub Unite Vaccine Market, By Region, From 2021 to 2026 (USD Million)
  150. Latin America Synthetic Vaccine Market, By Region, From 2021 to 2026 (USD Million)
  151. Brazil Vaccine Contract Manufacturing Market, By Service Type, From 2021 to 2026 (USD Million)
  152. Brazil Vaccine Contract Manufacturing Market, By Product Type, From 2021 to 2026 (USD Million)
  153. Brazil Vaccine Contract Manufacturing Market, By Vaccine Type, From 2021 to 2026 (USD Million)
  154. Argentina Vaccine Contract Manufacturing Market, By Service Type, From 2021 to 2026 (USD Million)
  155. Argentina Vaccine Contract Manufacturing Market, By Product Type, From 2021 to 2026 (USD Million)
  156. Argentina Vaccine Contract Manufacturing Market, By Vaccine Type, From 2021 to 2026 (USD Million)
  157. Mexico Vaccine Contract Manufacturing Market, By Service Type, From 2021 to 2026 (USD Million)
  158. Mexico Vaccine Contract Manufacturing Market, By Product Type, From 2021 to 2026 (USD Million)
  159. Mexico Vaccine Contract Manufacturing Market, By Vaccine Type, From 2021 to 2026 (USD Million)
  160. Rest of Latin America Vaccine Contract Manufacturing Market, By Service Type, From 2021 to 2026 (USD Million)
  161. Rest of Latin America Vaccine Contract Manufacturing Market, By Product Type, From 2021 to 2026 (USD Million)
  162. Rest of Latin America Vaccine Contract Manufacturing Market, By Vaccine Type, From 2021 to 2026 (USD Million)
  163. Latin America Vaccine Contract Manufacturing Market, By Single Vaccine, From 2021 to 2026 (USD Million)
  164. Latin America Influenza Virus Market, By Region, From 2021 to 2026 (USD Million)
  165. Latin America Chicken Pox Market, By Region, From 2021 to 2026 (USD Million)
  166. Latin America Ebola Virus Market, By Region, From 2021 to 2026 (USD Million)
  167. Latin America Tetanus Market, By Region, From 2021 to 2026 (USD Million)
  168. Latin America Tubercolosis Market, By Region, From 2021 to 2026 (USD Million)
  169. Latin America Polio Market, By Region, From 2021 to 2026 (USD Million)
  170. Latin America Small Pox Market, By Region, From 2021 to 2026 (USD Million)
  171. Brazil Vaccine Contract Manufacturing Market, By Single Vaccine, From 2021 to 2026 (USD Million)
  172. Argentina Vaccine Contract Manufacturing Market, By Single Vaccine, From 2021 to 2026 (USD Million)
  173. Mexico Vaccine Contract Manufacturing Market, By Single Vaccine, From 2021 to 2026 (USD Million)
  174. Middle East and Africa Vaccine Contract Manufacturing Market, By Service Type, From 2021 to 2026 (USD Million)
  175. Middle East and Africa Bulk Type Market, By Region, From 2021 to 2026 (USD Million)
  176. Middle East and Africa Fill Finish Market, By Region, From 2021 to 2026 (USD Million)
  177. Middle East and Africa Vaccine Contract Manufacturing Market, By Product Type, From 2021 to 2026 (USD Million)
  178. Middle East and Africa Single Vaccine Market, By Region, From 2021 to 2026 (USD Million)
  179. Middle East and Africa Combination Vaccine Market, By Region, From 2021 to 2026 (USD Million)
  180. Middle East and Africa Vaccine Contract Manufacturing Market, By Vaccine Type, From 2021 to 2026 (USD Million)
  181. Middle East and Africa Inactivated Vaccine Market, By Region, From 2021 to 2026 (USD Million)
  182. Middle East and Africa Conjugated Vaccine Market, By Region, From 2021 to 2026 (USD Million)
  183. Middle East and Africa Recombinant Vector Vaccine Market, By Region, From 2021 to 2026 (USD Million)
  184. Middle East and Africa Live Attenuated Vaccine Market, By Region, From 2021 to 2026 (USD Million)
  185. Middle East and Africa Toxoid Vaccine Market, By Region, From 2021 to 2026 (USD Million)
  186. Middle East and Africa Sub Unite Vaccine Market, By Region, From 2021 to 2026 (USD Million)
  187. Middle East and Africa Synthetic Vaccine Market, By Region, From 2021 to 2026 (USD Million)
  188. Middle East Vaccine Contract Manufacturing Market, By Service Type, From 2021 to 2026 (USD Million)
  189. Middle East Vaccine Contract Manufacturing Market, By Product Type, From 2021 to 2026 (USD Million)
  190. Middle East Vaccine Contract Manufacturing Market, By Vaccine Type, From 2021 to 2026 (USD Million)
  191. Africa Vaccine Contract Manufacturing Market, By Service Type, From 2021 to 2026 (USD Million)
  192. Africa Vaccine Contract Manufacturing Market, By Product Type, From 2021 to 2026 (USD Million)
  193. Africa Vaccine Contract Manufacturing Market, By Vaccine Type, From 2021 to 2026 (USD Million)
  194. Middle East and Africa Vaccine Contract Manufacturing Market, By Single Vaccine, From 2021 to 2026 (USD Million)
  195. Middle East and Africa Influenza Virus Market, By Region, From 2021 to 2026 (USD Million)
  196. Middle East and Africa Chicken Pox Market, By Region, From 2021 to 2026 (USD Million)
  197. Middle East and Africa Ebola Virus Market, By Region, From 2021 to 2026 (USD Million)
  198. Middle East and Africa Tetanus Market, By Region, From 2021 to 2026 (USD Million)
  199. Middle East and Africa Tubercolosis Market, By Region, From 2021 to 2026 (USD Million)
  200. Middle East and Africa Polio Market, By Region, From 2021 to 2026 (USD Million)
  201. Middle East and Africa Small Pox Market, By Region, From 2021 to 2026 (USD Million)
  202. Middle East Vaccine Contract Manufacturing Market, By Single Vaccine, From 2021 to 2026 (USD Million)
  203. Africa Vaccine Contract Manufacturing Market, By Single Vaccine, From 2021 to 2026 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 4255

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample